-transparent.png){kind=logo}
Nine women with postmenopausal spinal osteoporosis were treated with combination therapy consisting of estrogen, fluoride, and calcium. Their data were compared with those of a control group treated with fluoride, and calcium without estrogen. Bone mass was measured about every six months by photon absorptiometry (bone mineral content/bone width (BMC/BW)] and total-body neutron activation analysis [total-body calcium (TB Ca)]. Time-trend analysis revealed positive slopes for TB Ca (P = 0.002) and BMC/BW (P = N.S.) for the combination therapy group. The change in BMC/BW in the combination therapy group was significantly different from the response in the fluoride - calcium group. These data suggest that combination therapy may be successful in increasing bone mass in postmenopausal osteoporosis. A clinical trial to establish efficacy and examine risk/benefit ratios should be performed.
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
February 2004,
Nihon rinsho. Japanese journal of clinical medicine,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
November 1984,
Fortschritte der Medizin,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
January 1982,
Medizinische Klinik,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
December 1982,
Journal of the Oslo city hospitals,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
May 1964,
JAMA,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
August 1982,
The New England journal of medicine,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
July 1984,
American pharmacy,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
January 1990,
Progress in clinical and biological research,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
September 1970,
British medical journal,
J F Aloia, and
I Zanzi, and
A Vaswani, and
K Ellis, and
S H Cohn
October 1970,
British medical journal,
